http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f8a3453e089410dede9defcccfb61ca
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Gasser |
| name | Thomas Gasser |
| given-name | Thomas |
| organization-name | Department of Neurodegenerative Diseases University of Tuebingen Tuebingen Germany Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research University of Tubingen Tübingen Germany; German Center for Neurodegenerative Diseases Tübingen Germany Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Science Research, University of Tuebingen, Tuebingen, Germany. Department of Neurodegenerative Diseases, Hertie Institute of Clinical Brain Research, University of Tübingen, Tübingen, Germany Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. Hertie‐Institute for Clinical Brain Research Tübingen Germany; Department of Neurodegeneration University of Tübingen and German Centre for Neurodegenerative Diseases (DZNE) Department of Ophthalmology, Medical University Innsbruck, Innsbruck, Austria; Department for Neurodegenerative Diseases Hertie Institute for Clinical Brain Research, University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Germany. Department of Neurodegeneration Hertie‐Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases Tuebingen Germany From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of Tübingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany. Center of Neurology, Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases University of Tübingen Tuebingen Germany From Genetics and Epigenetics of Neurodegeneration (J.S.-S.) and Department of Neurodegenerative Diseases (T.G.), Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (J.S.-S., T.G.), Tübingen, Germany. From the Neurodegenerative Disease Research Unit (S.A., M.S.S., S.W.S.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Movement Disorders and Memory Unit (M.D.F., P.P.), Department of Neurology, University Hospital Mutua de Terrassa, and Fundació per la Recerca Biomèdica i Social Mútua Terrassa, Barcelona, Spain; Laboratory of Neurogenetics (J.D.), National Institutes on Aging, National Institutes of Health, Bethesda, MD; Neurology Service (L.I... Hertie Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, Tübingen, Germany. Thomas.gasser@uni-tuebingen.de From Muhammad Ali Parkinson Center (R.R.W.), Barrow Neurological Institute, Phoenix, AZ; Department of Neurology (F.K., G.K.W., W.P., K.S., N.S.), Medical University Innsbruck, Austria; National Institute of Neurological Disorders and Stroke (W.R.G., W.J.K.), NIH, Bethesda, MD; Department of Neurology (P.A.L.), Mayo Clinic, Rochester, MN; Brain and Mind Centre (G.H.), Sydney Medical School, the University of Sydney; UNSW Medicine & Neuroscience Research Australia (G.H.), Sydney; Queen Square... Authors' affiliations are listed at the end of the article. Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany Tübingen, Germany Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Tuebingen Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany Department of Neurosurgery, Goethe-University, Schleusenweg 2-16 60528 Frankfurt Germany Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Germany International Institute for Applied Systems Analysis (IIASA), Laxenburg2361, Austria Department for Neurodegenerative Diseases Hertie Institute for Clinical Brain Research Tubingen Germany Department of Neurodegenerative Diseases Hertie Institute for Clinical Brain Research, University of Tübingen and German Center for Neurodegenerative diseases (DZNE) Tübingen Germany for the United Kingdom Brain Expression Consortium (UKBEC) and the International Parkinson’s Disease Genomics Consortium (IPDGC) Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tu¨bingen, Tu¨bingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tu¨bingen, Germany. German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany; Department of Neurodegenerative Diseases Hertie Institute for Clinical Brain Research, University of Tübingen Tübingen Germany Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany Hertie Institut fuer klinische Hirnforschung Tuebingen Germany Center of Neurology, Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; German Center for Neurodegenerative Diseases University of Tuebingen Tuebingen Germany International Institute for Applied Systems Analysis (IIASA), Laxenburg A-2361, Austria From the Department of Neurology, Klinikum Groβhadern, Ludwig-Maximilians-Universität, Munich, Germany. Center of Neurology, Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany Department of Neurodegeneration; Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases; Tuebingen Germany Center of Neurology, Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany Department of Neurodegenerative Diseases, Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen and German Centre for Neurodegenerative Diseases, Tübingen, Germany Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Bonn Germany From the Department for Neurodegenerative Diseases (M.S., T.G., R.K.), Hertie Institute for Clinical Brain Research, University of Tübingen, and DZNE, German Centre for Neurodegenerative Diseases, Tübingen, Germany; Stanford Prevention Research Center (J.P.A.I.), Department of Medicine and Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA; Department of Neurology (J.O.A.), St Olavs Hospital and NTNU Trondheim, Trondheim, Norway; Institute of Neurological... German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany Neurologische Universitätsklinik, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany From the Centre for Genetic Epidemiology (S.G., A.A.K.S., M.S.), Institute for Clinical Epidemiology and Applied Biometry, University of Tubingen, Germany; Department of Neurology (L. Pihlstrom, M.T.), Oslo University Hospital, Norway; Université Paris-Saclay (C.D., P.E.S., O.M., B.P., A.E.), UVSQ, Univ. Paris-Sud, Inserm, Team “Exposome, heredity, cancer and health,” CESP, Villejuif, France; Department for Neurodegenerative Diseases (C.S., K.B., T.G., M.S.), Hertie Institute for Clinical Brain... Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany Department of Neurodegenerative Diseases Hertie Institute for Clinical Brain Research, University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany From the Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, Tübingen, Germany. Department of Neurodegenerative Diseases Hertie‐Institute for Clinical Brain Research, University of Tübingen Tübingen Germany From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Germany. Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. Department of Neurology, Klinikum Großhadern, Ludwig Maximilians Universität München, 81377 Munich, Germany Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany Department of Neurodegenerative Diseases , Hertie Institute for Clinical Brain Research, , 72076 Tübingen, Germany; University of Tübingen , Hertie Institute for Clinical Brain Research, , 72076 Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen , Germany Center of Neurology Department of Neurodegeneration and Hertie Institute of Clinical Brain Research University of Tübingen Tübingen Germany Center of Neurology Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; German Center for Neurodegenerative Diseases (DZNE University of Tuebingen Tuebingen Germany Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. International Institute for Applied Systems Analysis, 2361 Laxenburg, Austria; Urologische Universitätsklinik, Kantonsspital Baselland, Liestal German Center for Neurodegenerative Diseases (DZNE)‐Tübingen Tübingen Germany; Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA. From the Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research (K.B., K.S., A.-K.H., C.S., C.D.M., T.G., D.B.), University of Tübingen, Tübingen; German Center for Neurodegenerative Diseases (DZNE) (K.B., K.S., A.-K.H., C.S., T.G., D.B.), Bonn; Department of Neurology (R.H., S.B.) and Institut of Neuroradiology (U.P., J.M., E.H.), JW Goethe University, Frankfurt/Main; and Gertrudis Klinik (I.C.), Parkinson-Center, Leun-Biskirchen, Germany. Department of Urology University Hospital Basel, University of Basel Switzerland Tuebingen, Germany From the Swiss Group for Clinical Cancer Research (SAKK), and the Department of Urology, University of Bern, Bern, Switzerland Department of Urology, University Hospital Basel, Basel, Switzerland. Department of Neurology, University Hospital Tuebingen, Site Investigator Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tubingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tubingen, Germany Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510 Center of Neurology, Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tuebingen Tübingen Germany; German Center for Neurodegenerative Diseases University of Tuebingen Tuebingen Germany Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, German Centre for Neurodegenerative Diseases (DZNE), Tübingen, Germany Department for Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Centre of Neurodegenerative Diseases (DZNE) Tübingen Germany Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research University of Tubingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Tubingen Germany Department of Neurodegenerative Diseases, Hertie Center for Clinical Brain Research University of Tübingen Tübingen Germany Center of Neurology, and Hertie Institute for Clinical Brain Research University Hospital Tübingen Germany Zentrum für Neurologie, Hertie-Institut für klinische Hirnforschung, Abteilung Neurodegenerative Erkrankungen, Tübingen Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research University of Tubingen Tubingen Germany; German Center for Neurodegenerative Diseases (DZNE) Tubingen Germany From the Department of Neurology (Drs. Klopstock and Gasser)Klinikum Großhadern, Ludwig-Maximilians-University Munich; and the Institute of Clinical Chemistry (Dr. Jaksch), Molecular Diagnostics and Mitochondrial Genetics, Academic Hospital Schwabing, Munich, Germany. Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases University Clinic Tuebingen Tuebingen Germany Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany and Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany. German Center for Neurodegenerative Diseases Tübingen Germany From the Department of Neurology (S.T., D.L., C.P., F.P., S.P., F.H., S.K., G.D., G.K.), University Hospital Schleswig-Holstein, Kiel, Germany; Institute of Medical Informatics and Statistics (M.N.), Kiel, Germany; Institute of Experimental Medicine (S.A., G.K.) and Institute of Clinical Molecular Biology (A.N., S.S.), Christian-Albrechts-University Kiel, Kiel, Germany; Department of Neurology (A.-C.H., S.H., W.P.), Medical University Innsbruck, Innsbruck, Austria; Department of Neurodegenerative... Center of Neurology, Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tuebingen Tübingen Germany; German Center for Neurodegenerative Diseases University of Tuebingen Tuebingen Germany; Neurology Clinic, Henry Dunan Hospital Athens Greece Department of Neurodegeneration Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases Tuebingen Germany From the Department of Neurology, Klinikum Groβhadern, Ludwig-Maximilians-Universität München. Urologische Universitätsklinik Basel-Liestal, Kantonsspital Liestal Center of Neurology Department of Neurodegeneration and Hertie Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; German Center for Neurodegenerative Diseases University of Tuebingen Tuebingen Germany From The Dalglish Family 22q Clinic for Adults and Department of Psychiatry (E.B., A.M.F., A.S.B.), Toronto General Research Institute (A.S.B.), and Division of Cardiology, Department of Medicine (A.S.B.), University Health Network, Toronto, Canada; De Hartekamp Groep (E.B.), Centre for People with Intellectual Disability, Haarlem; Department of Nuclear Medicine (E.B., J.B.), Academic Medical Center, Amsterdam, the Netherlands; Clinical Genetics Research Program and Campbell Family Mental Health... From the Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology (J.T.G., L.H.S.), University of Pittsburgh, PA; and the Department of Neurology and Department of Neurodegenerative Diseases (T.G.), Hertie Institute for Clinical Brain Research, University of Tübingen, Germany. Department of Neurosurgery, University Hospital Essen, Essen, Germany. Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. From the Institut du Cerveau et de la Moelle épinière, ICM, Inserm U 1127, CNRS, UMR 7225, Sorbonne Universités, UPMC University Paris 06 UMR S 1127 (S.L., F.C.-D., C.C., A.N., A.B.), Paris, France; Centre d'Investigation Clinique Pitié Neurosciences CIC-1422 (F.C.-D.); AP-HP, Hôpital de la Salpêtrière (A.B.), Department of Genetics and Cytogenetics, Paris, France; Department of Molecular Neuroscience (J.B., L.D., R.G., M.F., N.W., J.H.), UCL Institute of Neurology, London, United Kingdom;... Department for Neurodegenerative Diseases Hertie Institute for Clinical Brain Research, University of Tübingen and German Center of Neurodegenerative Diseases (DZNE) Tübingen Germany Department of Neurosurgery, University of Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany. thomas.gasser@uk-essen.de Department of Neurodegeneration Hertie‐Institute for Clinical Brain Research Tübingen Germany Department of Neurosurgery, University of Essen, Essen, Germany Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research University of Tübingen and German Center of Neurodegenerative Diseases Tübingen Germany Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany,; DZNE – Deutsches Zentrum fur Neurodegenerative Erkrangungen (German Center for Neurodegenerative Diseases), Tuebingen, Germany, Department of Neurodegeneration Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases Tübingen Germany From the Hertie Institute for Clinical Brain Research (S.B., M.B., K.B., T.G., K.M., S.S., C.S., M.Z., D.B., I.L.-S.), Department of Neurodegenerative Diseases, University of Tübingen, Germany; Department of Psychology (S.B.), University of Calgary, AB, Canada; German Center for Neurodegenerative Diseases (DZNE) (M.B., K.B., T.G., K.M., S.S., C.S., M.Z., I.L.-S.), University of Tübingen; Diagnostics and Cognitive Neuropsychology (H.-C.N.), Department of Psychology, Eberhard Karls University Tübingen... Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases Tuebingen Germany Hertie Institute for Clinical Brain Research Tuebingen Germany; German Research Center for Neurodegenerative Diseases (DZNE) University of Tuebingen Tuebingen Germany Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen and German Centre for Neurodegenerative Diseases (DZNE), Tübingen, Germany. Center of Neurology, Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; German Center for Neurodegenerative Diseases, University of Tuebingen Tuebingen Germany |
Incoming Links
Total number of triples: 621.